Anticytokine agents: targeting interleukin signaling pathways for the treatment of atherothrombosis

PM Ridker - Circulation research, 2019 - Am Heart Assoc
The recognition that atherosclerosis is a complex chronic inflammatory disorder mediated
through both adaptive and innate immunity has led to the hypothesis that anticytokine …

[HTML][HTML] Anti-Cytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

PM Ridker - Circulation research, 2019 - ncbi.nlm.nih.gov
The recognition that atherosclerosis is a complex chronic inflammatory disorder mediated
through both adaptive and innate immunity has led to the hypothesis that anti-cytokine …

Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

PM Ridker - Circulation Research, 2019 - europepmc.org
The recognition that atherosclerosis is a complex chronic inflammatory disorder mediated
through both adaptive and innate immunity has led to the hypothesis that anti-cytokine …

Anticytokine Agents

PM Ridker - Circulation Research, 2019 - cir.nii.ac.jp
抄録< jats: p> The recognition that atherosclerosis is a complex chronic inflammatory
disorder mediated through both adaptive and innate immunity has led to the hypothesis that …

Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

PM Ridker - Circulation research, 2019 - pubmed.ncbi.nlm.nih.gov
The recognition that atherosclerosis is a complex chronic inflammatory disorder mediated
through both adaptive and innate immunity has led to the hypothesis that anticytokine …

Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis

PM Ridker - Circulation Research, 2019 - europepmc.org
The recognition that atherosclerosis is a complex chronic inflammatory disorder mediated
through both adaptive and innate immunity has led to the hypothesis that anti-cytokine …